Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
20.24
0.47 (2.38%)
At close: Aug 15, 2025, 3:45 PM
Enliven Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 316K | n/a | n/a | n/a | 440K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 74K | 158K | 80K | 79K | 79K | 77K | 79K | 74K | 67K | n/a | 104K | 495K | 25K | 25K | 24K | 25K | 25K |
Gross Profit | n/a | -74K | 158K | -80K | -79K | -79K | 363K | -79K | -74K | -67K | n/a | -104K | -495K | -25K | -25K | -24K | -25K | -25K |
Operating Income | -28.58M | -31.69M | -26.9M | -27.07M | -24.6M | -25.99M | -22.73M | -24.25M | -20.13M | -16.42M | -3.26M | -10.93M | -9.02M | -8.68M | -8.39M | -13.66M | -13.17M | -10.28M |
Interest Income | 3.25M | 3.2M | 3.72M | 3.84M | 4.09M | 3.25M | 3.37M | 3.49M | 3.41M | 1.69M | 613K | 380K | 127K | 9K | 3K | 30K | 48K | 83K |
Pretax Income | -25.34M | -28.54M | -23.18M | -23.16M | -19.72M | -22.74M | -19.37M | -20.77M | -16.72M | -14.72M | -9.55M | -4.61M | -11.45M | -14.64M | -14.32M | -13.65M | -13.16M | -10.26M |
Net Income | -25.34M | -28.54M | -23.18M | -23.16M | -19.95M | -22.74M | -19.37M | -20.77M | -16.72M | -14.72M | 32.19M | -10.55M | -8.89M | -8.67M | -8.39M | -13.65M | -13.16M | -10.26M |
Selling & General & Admin | 7.09M | 6.8M | 6.17M | 5.81M | 5.78M | 6.02M | 4.82M | 4.64M | 4.95M | 4.54M | 1.97M | 3.1M | 1.08M | 1.62M | 1.53M | 3.24M | 3.07M | 3.14M |
Research & Development | 21.49M | 24.89M | 20.72M | 21.26M | 18.83M | 19.89M | 17.83M | 19.61M | 15.18M | 11.88M | 180K | 7.83M | 7.94M | 7.06M | 6.86M | 10.4M | 10.07M | 7.12M |
Other Expenses | n/a | n/a | -80K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 28.58M | 31.69M | 26.82M | 27.07M | 24.6M | 25.91M | 22.65M | 24.25M | 20.13M | 16.42M | 3.26M | 10.93M | 9.02M | 8.68M | 8.39M | 13.63M | 13.14M | 10.26M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24K | -25K | -25K |
Cost & Expenses | n/a | 31.69M | 26.9M | 27.07M | 24.6M | 25.99M | 22.73M | 24.25M | 20.13M | 16.42M | 3.26M | 10.93M | 9.02M | 8.68M | 8.39M | 13.66M | 13.17M | 10.28M |
Income Tax Expense | n/a | n/a | n/a | n/a | 232K | n/a | n/a | n/a | -48.09K | n/a | 88K | 242K | -443K | 14K | 8K | 12K | 8K | 23K |
Shares Outstanding (Basic) | 52.11M | 50.05M | 49.86M | 48.27M | 48.08M | 42.05M | 41.13M | 41.03M | 40.96M | 18.52M | 6.57M | 6.57M | 6.57M | 6.57M | 6.57M | 6.22M | 4.43M | 4.39M |
Shares Outstanding (Diluted) | 52.11M | 50.05M | 49.86M | 48.27M | 48.08M | 42.05M | 41.13M | 41.03M | 40.96M | 18.52M | 6.57M | 6.57M | 6.57M | 6.57M | 6.57M | 6.22M | 4.43M | 4.39M |
EPS (Basic) | -0.49 | -0.57 | -0.46 | -0.48 | -0.41 | -0.54 | -0.47 | -0.51 | -0.41 | -0.8 | 4.90 | -0.7 | -1.74 | -2.23 | -2.18 | -2.19 | -2.97 | -2.33 |
EPS (Diluted) | -0.49 | -0.57 | -0.46 | -0.48 | -0.41 | -0.54 | -0.47 | -0.51 | -0.41 | -0.8 | 4.90 | -0.7 | -1.74 | -2.23 | -2.18 | -2.19 | -2.97 | -2.33 |
EBITDA | -28.58M | -31.69M | -26.82M | -26.99M | -24.52M | -25.91M | -22.65M | -24.17M | -20.06M | -16.35M | -10.1M | -10.87M | -8.96M | -8.64M | -8.36M | -13.62M | -13.14M | -10.23M |
EBIT | n/a | -28.54M | -26.9M | -27.07M | -24.6M | -25.99M | -22.73M | -24.25M | -18.83M | -16.42M | -10.16M | -10.93M | -9.02M | -8.68M | -8.39M | -13.65M | -13.16M | -10.26M |
Depreciation & Amortization | n/a | 74K | 80K | 80K | 78K | 79K | 77K | 78K | 74K | 67K | 64K | 104K | 495K | 25K | 25K | 24K | 25K | 25K |